share_log

CVS Health | 4: Statement of changes in beneficial ownership of securities-Officer Chaguturu Sreekanth K

CVS Health | 4: Statement of changes in beneficial ownership of securities

西維斯健康 | 4:持股變動聲明
美股SEC公告 ·  04/03 17:06

Moomoo AI 已提取核心訊息

On April 1, 2024, CVS Health EVP and Chief Medical Officer, Chaguturu Sreekanth K, completed a series of transactions involving the company's common stock. Initially, Chaguturu acquired 6,913 shares of restricted common stock at a price of $79.56 per share. Subsequently, he disposed of 2,298 shares at the same price, which were used to cover the exercise price or tax liability associated with the securities. After these transactions, Chaguturu Sreekanth K's direct holdings in CVS Health totaled 23,666 shares. The total market value of the disposed shares amounted to $182,828.88.
On April 1, 2024, CVS Health EVP and Chief Medical Officer, Chaguturu Sreekanth K, completed a series of transactions involving the company's common stock. Initially, Chaguturu acquired 6,913 shares of restricted common stock at a price of $79.56 per share. Subsequently, he disposed of 2,298 shares at the same price, which were used to cover the exercise price or tax liability associated with the securities. After these transactions, Chaguturu Sreekanth K's direct holdings in CVS Health totaled 23,666 shares. The total market value of the disposed shares amounted to $182,828.88.
2024年4月1日,CVS Health執行副總裁兼首席醫療官Chaguturu Sreekanth K完成了一系列涉及公司普通股的交易。最初,查古圖魯以每股79.56美元的價格收購了6,913股限制性普通股。隨後,他以相同的價格出售了2,298股股票,用於支付與證券相關的行使價或納稅義務。交易完成後,Chaguturu Sreekanth K在CVS Health的直接持股總額爲23,666股。已處置股份的總市值爲182,828.88美元。
2024年4月1日,CVS Health執行副總裁兼首席醫療官Chaguturu Sreekanth K完成了一系列涉及公司普通股的交易。最初,查古圖魯以每股79.56美元的價格收購了6,913股限制性普通股。隨後,他以相同的價格出售了2,298股股票,用於支付與證券相關的行使價或納稅義務。交易完成後,Chaguturu Sreekanth K在CVS Health的直接持股總額爲23,666股。已處置股份的總市值爲182,828.88美元。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息